Genoox
VerifiedA healthcare and technology company on a mission to make clinical genetic sequencing more accessible.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$32—48m (Dealroom.co estimates Feb 2021.)
Palo Alto California (HQ), Tel Aviv-Yafo Tel Aviv District (founding location)
| USD | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | - | 10 % | 3 % | 15 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 |
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | $0.0 | round |
| investor | $0.0 | round | |
| investor | $0.0 | round | |
| investor | $0.0 | round | |
| investor investor | $0.0 | round | |
| investor investor investor | $0.0 | round | |
$8.0m | Series B | ||
| Total Funding | 000k | ||
RELATED LANDSCAPES AND LISTS
Related Content
Recent News about Genoox
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.